Glaukos Corp (GKOS): R&D Expense
$150.61M
Year ended 2025-12-31
$177.17M
Trailing 12 months to 2026-06-30
+6.9%
3-year compound annual growth
+12.0%
5-year compound annual growth
+19.6%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $150.61M | +10.4% | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | $136.43M | -1.7% | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | $138.77M | +12.6% | 2026-02-23, From 2023-01-01 |
| 2022-12-31 | $123.27M | +22.1% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $101.00M | +18.3% | 2024-02-23, From 2021-01-01 |
| 2020-12-31 | $85.39M | +25.0% | 2023-02-24, From 2020-01-01 |
| 2019-12-31 | $68.31M | +37.5% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $49.68M | +27.7% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $38.91M | +33.1% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $29.22M | +16.7% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $25.05M | +30.4% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $19.20M | +23.8% | 2017-03-15, From 2014-01-01 |
| 2013-12-31 | $15.51M | n/a | 2016-03-15, From 2013-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Glaukos Corp (GKOS) | 2025-12-31 | $150.61M | +10.4% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $99.21M | +3.2% |
| Bioventus Inc. (BVS) | 2025-12-31 | $12.11M | -13.2% |
| Artivion, Inc. (AORT) | 2025-12-31 | $30.99M | +8.9% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $8.60M | -17.3% |
| Mimedx Group, Inc. (MDXG) | 2025-12-31 | $15.10M | +22.3% |
| Accuray Inc (ARAY) | 2026-06-30 | $37.75M | -21.3% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $224.54M | +7.1% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $84.61M | +18.4% |
Compare GKOS, ATRC, BVS, AORT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗